血小板の世界市場 2025

世界の血小板の市場規模は、2025年の32億ドルから、予測期間中は4.6％のCAGRで推移し、2030年末には40億ドルに成長すると予測されています。

北米市場は、2025年の11億ドルから、予測期間中はCAGR 3.8%で推移し、2030年末には13億ドルに達すると予測されています。欧州市場は、2025年の9億4,050万ドルから、予測期間中はCAGR 4.7%で推移し、2030年末には12億ドルに達すると予測されています。

当レポートでは、世界の血小板の市場を調査し、市場概要、市場影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の詳細分析などをまとめています。

目次

第1章 エグゼクティブサマリー

• 市場見通し
• 調査範囲
• 市場サマリー
• 市場力学と成長要因
• 新興技術
• セグメント分析
• 地域分析
• 結論

第2章 市場概要

• 献血に関する主要な統計
• 血小板献血に適した血液型
• 血小板提供のプロセス
• ポーターのファイブフォース分析
• マクロ経済要因分析
• 経済成長と医療費支出
• 世界の人口の高齢化
• 政府の規制と健康政策
• 世界の疾病負担
• インフレの上昇と献血サービスのコスト
• 米国の関税が血小板市場に与える影響

第3章 市場力学

• 市場力学
• 市場促進要因
• 外科手術件数の増加
• 献血の重要性への理解の深まり
• 政府の取り組みの高まり
• 慢性血液関連疾患の有病率
• 市場抑制要因
• 血小板輸血処置における感染リスクの上昇
• 血小板輸血の高額な費用
• 血小板サプライチェーンと物流における課題
• 献血者不足
• 市場機会
• 再生医療とバイオテクノロジーにおける献血血小板の利用増加
• 新興市場からの需要と医療インフラの拡大

第4章 規制状況

• 血小板市場に関する規制の洞察

第5章 新興技術

• 概要
• 新興技術
• 血小板採取における病原体低減技術の進歩
• 血小板保存システムの開発
• 血液採取と処理におけるAIと自動化の統合

第6章 市場セグメンテーション分析

• セグメンテーションの内訳
• 市場内訳：血小板タイプ別
• 重要ポイント
• アフェレーシス由来血小板
• 全血由来血小板
• 市場内訳：用途別
• 重要ポイント
• がん治療
• 外科手術
• 慢性疾患の治療
• 外傷
• 血小板減少症（非がん性）
• 血小板機能障害
• 市場内訳：エンドユーザー別
• 重要ポイント
• 病院・診療所
• 外来手術センター
• 血液バンク・輸血センター
• 研究ラボ
• がん治療センター
• その他
• 地理的内訳
• 市場内訳：地域別
• 重要ポイント
• 北米
• 欧州
• アジア太平洋
• 南米
• 中東・アフリカ

第7章 競合情報

• 重要ポイント
• 競合情勢
• 世界中の主要組織のリスト
• 主な発展と戦略
• 提携・協力
• 事業とサービスの拡大
• 技術開発
• 規制と法律の動向

第8章 環境・社会・ガバナンス (ESG ) の観点

• ESG：イントロダクション
• 血小板市場における持続可能性
• BCCによる総論

第9章 付録

• 調査手法
• 参考文献
• 略語
• 企業プロファイル
• AABB - ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
• AMERICA'S BLOOD CENTERS
• AUSTRALIAN RED CROSS LIFEBLOOD
• BELGIAN RED CROSS-FLANDERS
• BLOOD BANK OF ALASKA
• BLOOD CENTERS OF AMERICA
• CANADIAN BLOOD SERVICES
• EUROPEAN BLOOD ALLIANCE
• FINNISH RED CROSS BLOOD SERVICE
• INDIAN RED CROSS SOCIETY
• JAPANESE RED CROSS SOCIETY
• ONEBLOOD
• SANBS
• THE AMERICAN NATIONAL RED CROSS
• VITALANT

List of Tables

• Summary Table : Global Market for Blood Platelets, by Region, Through 2030
• Table 1 : Platelet Use by Patients in the U.S., 2024
• Table 2 : Prevalence of Each Blood Type Among the U.S. Population, by Blood Type, 2024
• Table 3 : Prevalence of Each Blood Type Among the U.S. Population, by Race, 2024
• Table 4 : Tests Used in the U.S. to Screen Donated Blood
• Table 5 : Risk of Acquiring Infectious Disease Through Blood Transfusions
• Table 6 : Comparison Between Whole Blood-Derived and Apheresis-Derived Platelets
• Table 7 : Porter's Five Forces: Rating Scale
• Table 8 : Viral Infections and Their Transmission Risks in Blood Transfusions
• Table 9 : Regulatory Landscape Governing Blood Platelets, by Country
• Table 10 : Global Market for Blood Platelets, by Platelet Type, Through 2030
• Table 11 : Global Market for Apheresis-Derived Platelets, by Region, Through 2030
• Table 12 : Global Market for Whole Blood-Derived Platelets, by Region, Through 2030
• Table 13 : Global Market for Blood Platelets, by Application, Through 2030
• Table 14 : Global Market for Blood Platelets in Cancer Treatment, by Region, Through 2030
• Table 15 : Global Market for Blood Platelets in Surgical Procedures, by Region, Through 2030
• Table 16 : Global Market for Blood Platelets in Chronic Disease Treatment, by Region, Through 2030
• Table 17 : Global Market for Blood Platelets in Traumatic Injuries, by Region, Through 2030
• Table 18 : Global Market for Blood Platelets in Thrombocytopenia (Non-Cancer Related) Treatment, by Region, Through 2030
• Table 19 : Global Market for Blood Platelets in Platelet Function Disorder Treatment, by Region, Through 2030
• Table 20 : Global Market for Blood Platelets, by End User, Through 2030
• Table 21 : Global Market for Blood Platelets in Hospitals and Clinics, by Region, Through 2030
• Table 22 : Global Market for Blood Platelets in Ambulatory Surgical Centers, by Region, Through 2030
• Table 23 : Global Market for Blood Platelets in Blood Banks and Transfusion Centers, by Region, Through 2030
• Table 24 : Global Market for Blood Platelets in Research Laboratories, by Region, Through 2030
• Table 25 : Global Market for Blood Platelets in Cancer Treatment Centers, by Region, Through 2030
• Table 26 : Global Market for Blood Platelets in Other End Users, by Region, Through 2030
• Table 27 : Global Market for Blood Platelets, by Region, Through 2030
• Table 28 : North American Market for Blood Platelets, by Country, Through 2030
• Table 29 : North American Market for Blood Platelets, by Platelet Type, Through 2030
• Table 30 : North American Market for Blood Platelets, by Application, Through 2030
• Table 31 : North American Market for Blood Platelets, by End User, Through 2030
• Table 32 : European Market for Blood Platelets, by Country, Through 2030
• Table 33 : European Market for Blood Platelets, by Platelet Type, Through 2030
• Table 34 : European Market for Blood Platelets, by Application, Through 2030
• Table 35 : European Market for Blood Platelets, by End User, Through 2030
• Table 36 : Asia-Pacific Market for Blood Platelets, by Country, Through 2030
• Table 37 : Asia-Pacific Market for Blood Platelets, by Platelet Type, Through 2030
• Table 38 : Asia-Pacific Market for Blood Platelets, by Application, Through 2030
• Table 39 : Asia-Pacific Market for Blood Platelets, by End User, Through 2030
• Table 40 : South American Market for Blood Platelets, by Country, Through 2030
• Table 41 : South American Market for Blood Platelets, by Platelet Type, Through 2030
• Table 42 : South American Market for Blood Platelets, by Application, Through 2030
• Table 43 : South American Market for Blood Platelets, by End User, Through 2030
• Table 44 : MEA Market for Blood Platelets, by Subregion, Through 2030
• Table 45 : MEA Market for Blood Platelets, by Platelet Type, Through 2030
• Table 46 : MEA Market for Blood Platelets, by Application, Through 2030
• Table 47 : MEA Market for Blood Platelets, by End User, Through 2030
• Table 48 : Key Providers of Blood Platelets, 2024
• Table 49 : Key Partnerships and Collaborations in the Blood Platelet Market, 2024
• Table 50 : Business Expansions in the Blood Platelet Market, 2023-2025
• Table 51 : Technological Developments in the Blood Platelets Market, 2023
• Table 52 : Key Regulatory and Legal Developments in the Blood Platelet Market, 2023
• Table 53 : Sustainability Initiatives by Key Organizations, 2023 and 2024
• Table 54 : Abbreviations Used in the Report
• Table 55 : AABB - Association for the Advancement of Blood & Biotherapies: Company Snapshot
• Table 56 : AABB - Association for the Advancement of Blood & Biotherapies: Product Portfolio
• Table 57 : AABB - Association for the Advancement of Blood & Biotherapies: News/Key Developments, 2023
• Table 58 : America's Blood Centers: Company Snapshot
• Table 59 : America's Blood Centers: Product Portfolio
• Table 60 : Australian Red Cross Lifeblood: Company Snapshot
• Table 61 : Australian Red Cross Lifeblood: Financial Performance, FY 2022 and 2023
• Table 62 : Australian Red Cross Lifeblood: Product Portfolio
• Table 63 : Australian Red Cross Lifeblood: News/Key Developments, 2023 and 2024
• Table 64 : Belgian Red Cross-Flanders: Company Snapshot
• Table 65 : Belgian Red Cross-Flanders: Product Portfolio
• Table 66 : Belgian Red Cross-Flanders: News/Key Developments, 2024
• Table 67 : Blood Bank of Alaska: Company Snapshot
• Table 68 : Blood Bank of Alaska: Product Portfolio
• Table 69 : Blood Centers of America: Company Snapshot
• Table 70 : Blood Centers of America: Product Portfolio
• Table 71 : Blood Centers of America: News/Key Developments, 2023 and 2024
• Table 72 : Canadian Blood Services: Company Snapshot
• Table 73 : Canadian Blood Services: Financial Performance, FY 2022 and 2023
• Table 74 : Canadian Blood Services: Product Portfolio
• Table 75 : Canadian Blood Services: News/Key Developments, 2025
• Table 76 : European Blood Alliance: Company Snapshot
• Table 77 : European Blood Alliance: Product Portfolio
• Table 78 : Finnish Red Cross Blood Service: Company Snapshot
• Table 79 : Finnish Red Cross Blood Service: Financial Performance, FY 2023 and 2024
• Table 80 : Finnish Red Cross Blood Service: Product Portfolio
• Table 81 : Finnish Red Cross Blood Service: News/Key Developments, 2023-2025
• Table 82 : Indian Red Cross Society: Company Snapshot
• Table 83 : Indian Red Cross Society: Product Portfolio
• Table 84 : Japanese Red Cross Society: Company Snapshot
• Table 85 : Japanese Red Cross Society: Product Portfolio
• Table 86 : OneBlood: Company Snapshot
• Table 87 : OneBlood: Product Portfolio
• Table 88 : OneBlood: News/Key Developments, 2023
• Table 89 : SANBS: Company Snapshot
• Table 90 : SANBS: Financial Performance, FY 2022 and 2023
• Table 91 : SANBS: Product Portfolio
• Table 92 : The American National Red Cross: Company Snapshot
• Table 93 : The American National Red Cross: Product Portfolio
• Table 94 : The American National Red Cross: News/Key Developments, 2024-2025
• Table 95 : Vitalant: Company Snapshot
• Table 96 : Vitalant: Product Portfolio
• Table 97 : Vitalant: News/Key Developments, 2023

List of Figures

• Summary Figure : Global Market Shares of Blood Platelets, by Region, 2024
• Figure 1 : Insights and Statistics on Blood Donations
• Figure 2 : Journey of Whole Blood-Derived Platelets
• Figure 3 : Porter's Five Forces Analysis of the Global Blood Platelet Market
• Figure 4 : Snapshot of the Dynamics of the Blood Platelet Market
• Figure 5 : Organ Transplant Procedures Performed, by Organ Type, 2023
• Figure 6 : Emerging Technologies in the Blood Platelet Market
• Figure 7 : Global Market Shares of Blood Platelets, by Platelet Type, 2024
• Figure 8 : Advantages of Apheresis-Derived Platelets
• Figure 9 : Global Market Shares of Apheresis-Derived Platelets, by Region, 2024
• Figure 10 : Global Market Shares of Whole Blood-Derived Platelets, by Region, 2024
• Figure 11 : Global Market Shares of Blood Platelets, by Application, 2024
• Figure 12 : Global Market Shares of Blood Platelets in Cancer Treatment, by Region, 2024
• Figure 13 : Global Market Shares of Blood Platelets in Surgical Procedures, by Region, 2024
• Figure 14 : Global Market Shares of Blood Platelets in Chronic Disease Treatment, by Region, 2024
• Figure 15 : Global Market Shares of Blood Platelets in Traumatic Injuries, by Region, 2024
• Figure 16 : Global Market Shares of Blood Platelets in Thrombocytopenia (Non-Cancer Related) Treatment, by Region, 2030
• Figure 17 : Global Market Shares of Blood Platelets in Platelet Function Disorder Treatment, by Region, 2030
• Figure 18 : Global Market Shares of Blood Platelets, by End User, 2024
• Figure 19 : Global Market Shares of Blood Platelets in Hospitals and Clinics, by Region, 2024
• Figure 20 : Global Market Shares of Blood Platelets in Ambulatory Surgical Centers, by Region, 2024
• Figure 21 : Global Market Shares of Blood Platelets in Blood Banks and Transfusion Centers, by Region, 2024
• Figure 22 : Global Market Shares of Blood Platelets in Research Laboratories, by Region, 2024
• Figure 23 : Global Market Shares of Blood Platelets in Cancer Treatment Centers, by Region, 2024
• Figure 24 : Global Market Shares of Blood Platelets in Other End Users, by Region, 2024
• Figure 25 : Global Market Shares of Blood Platelets, by Region, 2024
• Figure 26 : Snapshot of the ESG Pillars
• Figure 27 : Australian Red Cross Lifeblood: Revenue Shares, by Business Segment, FY 2023
• Figure 28 : Canadian Blood Services: Revenue Shares, by Business Segment, FY 2023
• Figure 29 : Finnish Red Cross Blood Service: Revenue Shares, by Business Segment, FY 2024

The global market for blood platelets is expected to grow from $3.2 billion in 2025 and is projected to reach $4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 4.6% during the forecast period of 2025 to 2030.

The North American market for blood platelets is expected to grow from $1.1 billion in 2025 and is projected to reach $1.3 billion by the end of 2030, at a CAGR of 3.8% during the forecast period of 2025 to 2030.

The European market for blood platelets is expected to grow from $940.5 million in 2025 and is projected to reach $1.2 billion by the end of 2030, at a CAGR of 4.7% during the forecast period of 2025 to 2030.

Report Scope

The report provides an overview of the global blood platelet market and analyzes market trends. It includes global revenue ($ million) for base year 2024, estimates for 2025 and a forecast period through 2030. The market is segmented based on platelet type, application, end user and region. The regions covered in this study include North America, Europe, Asia-Pacific, South America, and the Middle East and Africa, focusing on major countries in these regions.

The report examines the significant trends and challenges that affect the market and blood donation landscape. It analyzes environmental, social and corporate governance (ESG) developments and discusses patents and emerging technologies related to the market.

The report provides an in-depth analysis of the global blood platelets market, with a comprehensive evaluation of the value chain from blood platelets collection to end-use applications. The scope encompasses the activities of blood collection organizations, which are responsible for the voluntary collection of blood donations in each country. These organizations play a critical role in separating, processing and storing platelets from donated blood and ensuring their timely and safe distribution to various healthcare settings.

The market analysis covers the distribution of collected blood platelets to various end users, including hospitals, clinics, ambulatory surgical centers, cancer treatment centers, blood banks and transfusion centers. These facilities use blood platelets for multiple clinical and therapeutic purposes.

The report also examines the operational models of independent and government-funded organizations while also analyzing regulatory frameworks related to platelet donation, safety protocols and distribution standards across the market.

The report concludes with an analysis of the competitive landscape, providing a list of key organizations in the global blood platelet market. It also includes a dedicated section of company profiles that outlines details about leading market enterprises.

Report Includes

• 45 data tables and 53 additional tables
• Overview and analysis of the global market for blood platelets, also known as thrombocytes
• Analyses of global market trends, with revenue data for 2022-2024, estimates for 2025, and projected CAGRs through 2030
• Estimates of the size and revenue prospects for the global blood platelet market, along with a market share analysis by platelet type, application, end-user, and region
• Facts and figures pertaining to market dynamics, opportunities and deterrents, technological advances, government policies and regulations and the impacts of macroeconomic variables
• Insights derived from the Porter's Five Forces model, as well as global supply chain and PESTLE analyses
• An assessment of the current market environment, innovation and prospects, emerging technologies, new developments, and products in the pipeline
• Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices followed by leading companies, their ESG ratings and consumer attitudes
• Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
• Profiles of the leading companies, including American National Red Cross, Vitalant, Canadian Blood Services, NHS Blood and Transplant, and Red Cross Society of China

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of the Report
• Market Summary
• Market Dynamics and Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion

Chapter 2 Market Overview

• Introduction
• Key Statistics About Blood Donations
• Blood Types Suitable for Platelet Donations
• Platelet Donation Process
• Porter's Five Forces Analysis
• Threat of New Entrants (Moderate to High)
• Bargaining Power of Suppliers (Moderate)
• Bargaining Power of Buyers (Moderate to High)
• Threat of Substitutes (Very Low)
• Level of Competitiveness (Moderate)
• Macroeconomic Factor Analysis
• Economic Growth and Healthcare Spending
• An Aging Population Worldwide
• Government Regulations and Health Policies
• Global Disease Burden
• Rising Inflation and Cost of Blood Donation Services
• Impact of Ongoing Tariffs Imposed by the U.S. on the Blood Platelet Market

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Increased Number of Surgical Procedures
• Better Awareness of the Importance of Blood Donations
• Rising Government Initiatives
• Prevalence of Chronic Blood-Related Disorders
• Market Restraints
• Elevated Risk of Infection in Platelet Transfusion Procedures
• High Cost of Platelet Transfusions
• Challenges in Blood Platelet Supply Chain and Logistics
• Shortage of Blood Donors
• Market Opportunities
• Increased Use of Donated Blood Platelets in Regenerative Medicine and Biotechnology
• Demand from Emerging Markets and Expanding Healthcare Infrastructure

Chapter 4 Regulatory Landscape

• Regulatory Insights into the Blood Platelet Market

Chapter 5 Emerging Technologies

• Overview
• Emerging Technologies
• Advances in Pathogen Reduction Techniques for Platelet Collection
• Developments in Platelet Storage Systems
• Integration of AI and Automation in Blood Collection and Processing

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Market Breakdown by Platelet Type
• Key Takeaways
• Apheresis-Derived Platelets
• Whole Blood-Derived Platelets
• Market Breakdown by Application
• Key Takeaways
• Cancer Treatment
• Surgical Procedures
• Chronic Disease Treatment
• Traumatic Injury
• Thrombocytopenia (Non-Cancer Related)
• Platelet Function Disorder
• Market Breakdown by End User
• Key Takeaways
• Hospitals and Clinics
• Ambulatory Surgical Centers
• Blood Banks and Transfusion Centers
• Research Laboratories
• Cancer Treatment Centers
• Others
• Geographic Breakdown
• Market Breakdown by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

Chapter 7 Competitive Intelligence

• Key Takeaways
• Competitive Landscape
• List of Leading Organizations Across the Globe
• Key Developments and Strategies
• Partnerships and Collaborations
• Business and Service Expansions
• Technological Developments
• Regulatory and Legal Developments

Chapter 8 Environmental, Social and Governance (ESG) Perspective

• Introduction to ESG
• Sustainability in the Blood Platelet Market
• Concluding Remarks from BCC

Chapter 9 Appendix

• Research Methodology
• References
• Abbreviations
• Company Profiles
• AABB - ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
• AMERICA'S BLOOD CENTERS
• AUSTRALIAN RED CROSS LIFEBLOOD
• BELGIAN RED CROSS-FLANDERS
• BLOOD BANK OF ALASKA
• BLOOD CENTERS OF AMERICA
• CANADIAN BLOOD SERVICES
• EUROPEAN BLOOD ALLIANCE
• FINNISH RED CROSS BLOOD SERVICE
• INDIAN RED CROSS SOCIETY
• JAPANESE RED CROSS SOCIETY
• ONEBLOOD
• SANBS
• THE AMERICAN NATIONAL RED CROSS
• VITALANT